Therapeutic Potential of Engineered Extracellular Vesicles

Extracellular vesicles (EVs) comprise a heterogeneous group of small membrane vesicles, including exosomes, which play a critical role in intracellular communication and regulation of numerous physiological processes in health and disease. Naturally released from virtually all cells, these vesicles...

Full description

Saved in:
Bibliographic Details
Published in:The AAPS journal 2018-03, Vol.20 (3), p.50-50, Article 50
Main Authors: Mentkowski, Kyle I., Snitzer, Jonathan D., Rusnak, Sarah, Lang, Jennifer K.
Format: Article
Language:English
Subjects:
Apoptosis
Biochemistry
Biocompatible Materials
Biomedical and Life Sciences
Biomedicine
Biomimetics
Biotechnology
Cell Engineering
Drug Delivery Systems
Extracellular Vesicles
Humans
Pharmacology/Toxicology
Pharmacy
Review Article
Terminology as Topic
Theme: Therapeutic and Diagnostic Applications of Exosomes and other Extracellular Vesicles
Therapeutics
Tissue Distribution
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-1929dc15d5aebdef077266b0a41e59f478735416823bff4a0276ddae7f830c603
cites cdi_FETCH-LOGICAL-c442t-1929dc15d5aebdef077266b0a41e59f478735416823bff4a0276ddae7f830c603
container_end_page 50
container_issue 3
container_start_page 50
container_title The AAPS journal
container_volume 20
creator Mentkowski, Kyle I.
Snitzer, Jonathan D.
Rusnak, Sarah
Lang, Jennifer K.
description Extracellular vesicles (EVs) comprise a heterogeneous group of small membrane vesicles, including exosomes, which play a critical role in intracellular communication and regulation of numerous physiological processes in health and disease. Naturally released from virtually all cells, these vesicles contain an array of nucleic acids, lipids and proteins which they transfer to target cells within their local milieu and systemically. They have been proposed as a means of “cell-free, cell therapy” for cancer, immune disorders, and more recently cardiovascular disease. In addition, their unique properties of stability, biocompatibility, and low immunogenicity have prompted research into their potential as therapeutic delivery agents for drugs and small molecules. In this review, we aim to provide a comprehensive overview of the current understanding of extracellular vesicle biology as well as engineering strategies in play to improve their therapeutic potential.
doi_str_mv 10.1208/s12248-018-0211-z
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8299397</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>29546642</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-1929dc15d5aebdef077266b0a41e59f478735416823bff4a0276ddae7f830c603</originalsourceid><addsrcrecordid>eNp9kM9Kw0AQxhdRbK0-gBfJC0R3Npts4kGQEv9AQQ_V67LZzLYpaVJ2E9E-vVuipV48DDPwzffN8CPkEug1MJreOGCMpyEFXwwg3B6RMcQxDQWH5PhgHpEz51aURiwCOCUjlsU8STgbk9v5Eq3aYN9VOnhtO2y6StVBa4K8WVQNosUyyD87qzTWdV8rG7yjq3SN7pycGFU7vPjpE_L2kM-nT-Hs5fF5ej8LNeesCyFjWakhLmOFRYmGCsGSpKCKA8aZ4SIVUex_TFlUGMMVZSIpS4XCpBHVCY0m5G7I3fTFGkvtX7SqlhtbrZX9kq2q5F-lqZZy0X7IlGVZlAkfAEOAtq1zFs3eC1TuQMoBpPQg5Q6k3HrP1eHRveOXnF9gw4LzUrNAK1dtbxsP4p_Ub1I5gC8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Therapeutic Potential of Engineered Extracellular Vesicles</title><source>Springer Nature</source><creator>Mentkowski, Kyle I. ; Snitzer, Jonathan D. ; Rusnak, Sarah ; Lang, Jennifer K.</creator><creatorcontrib>Mentkowski, Kyle I. ; Snitzer, Jonathan D. ; Rusnak, Sarah ; Lang, Jennifer K.</creatorcontrib><description>Extracellular vesicles (EVs) comprise a heterogeneous group of small membrane vesicles, including exosomes, which play a critical role in intracellular communication and regulation of numerous physiological processes in health and disease. Naturally released from virtually all cells, these vesicles contain an array of nucleic acids, lipids and proteins which they transfer to target cells within their local milieu and systemically. They have been proposed as a means of “cell-free, cell therapy” for cancer, immune disorders, and more recently cardiovascular disease. In addition, their unique properties of stability, biocompatibility, and low immunogenicity have prompted research into their potential as therapeutic delivery agents for drugs and small molecules. In this review, we aim to provide a comprehensive overview of the current understanding of extracellular vesicle biology as well as engineering strategies in play to improve their therapeutic potential.</description><identifier>ISSN: 1550-7416</identifier><identifier>EISSN: 1550-7416</identifier><identifier>DOI: 10.1208/s12248-018-0211-z</identifier><identifier>PMID: 29546642</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Apoptosis ; Biochemistry ; Biocompatible Materials ; Biomedical and Life Sciences ; Biomedicine ; Biomimetics ; Biotechnology ; Cell Engineering ; Drug Delivery Systems ; Extracellular Vesicles ; Humans ; Pharmacology/Toxicology ; Pharmacy ; Review Article ; Terminology as Topic ; Theme: Therapeutic and Diagnostic Applications of Exosomes and other Extracellular Vesicles ; Therapeutics ; Tissue Distribution</subject><ispartof>The AAPS journal, 2018-03, Vol.20 (3), p.50-50, Article 50</ispartof><rights>The Author(s) 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-1929dc15d5aebdef077266b0a41e59f478735416823bff4a0276ddae7f830c603</citedby><cites>FETCH-LOGICAL-c442t-1929dc15d5aebdef077266b0a41e59f478735416823bff4a0276ddae7f830c603</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29546642$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mentkowski, Kyle I.</creatorcontrib><creatorcontrib>Snitzer, Jonathan D.</creatorcontrib><creatorcontrib>Rusnak, Sarah</creatorcontrib><creatorcontrib>Lang, Jennifer K.</creatorcontrib><title>Therapeutic Potential of Engineered Extracellular Vesicles</title><title>The AAPS journal</title><addtitle>AAPS J</addtitle><addtitle>AAPS J</addtitle><description>Extracellular vesicles (EVs) comprise a heterogeneous group of small membrane vesicles, including exosomes, which play a critical role in intracellular communication and regulation of numerous physiological processes in health and disease. Naturally released from virtually all cells, these vesicles contain an array of nucleic acids, lipids and proteins which they transfer to target cells within their local milieu and systemically. They have been proposed as a means of “cell-free, cell therapy” for cancer, immune disorders, and more recently cardiovascular disease. In addition, their unique properties of stability, biocompatibility, and low immunogenicity have prompted research into their potential as therapeutic delivery agents for drugs and small molecules. In this review, we aim to provide a comprehensive overview of the current understanding of extracellular vesicle biology as well as engineering strategies in play to improve their therapeutic potential.</description><subject>Apoptosis</subject><subject>Biochemistry</subject><subject>Biocompatible Materials</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biomimetics</subject><subject>Biotechnology</subject><subject>Cell Engineering</subject><subject>Drug Delivery Systems</subject><subject>Extracellular Vesicles</subject><subject>Humans</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Review Article</subject><subject>Terminology as Topic</subject><subject>Theme: Therapeutic and Diagnostic Applications of Exosomes and other Extracellular Vesicles</subject><subject>Therapeutics</subject><subject>Tissue Distribution</subject><issn>1550-7416</issn><issn>1550-7416</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kM9Kw0AQxhdRbK0-gBfJC0R3Npts4kGQEv9AQQ_V67LZzLYpaVJ2E9E-vVuipV48DDPwzffN8CPkEug1MJreOGCMpyEFXwwg3B6RMcQxDQWH5PhgHpEz51aURiwCOCUjlsU8STgbk9v5Eq3aYN9VOnhtO2y6StVBa4K8WVQNosUyyD87qzTWdV8rG7yjq3SN7pycGFU7vPjpE_L2kM-nT-Hs5fF5ej8LNeesCyFjWakhLmOFRYmGCsGSpKCKA8aZ4SIVUex_TFlUGMMVZSIpS4XCpBHVCY0m5G7I3fTFGkvtX7SqlhtbrZX9kq2q5F-lqZZy0X7IlGVZlAkfAEOAtq1zFs3eC1TuQMoBpPQg5Q6k3HrP1eHRveOXnF9gw4LzUrNAK1dtbxsP4p_Ub1I5gC8</recordid><startdate>20180315</startdate><enddate>20180315</enddate><creator>Mentkowski, Kyle I.</creator><creator>Snitzer, Jonathan D.</creator><creator>Rusnak, Sarah</creator><creator>Lang, Jennifer K.</creator><general>Springer International Publishing</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20180315</creationdate><title>Therapeutic Potential of Engineered Extracellular Vesicles</title><author>Mentkowski, Kyle I. ; Snitzer, Jonathan D. ; Rusnak, Sarah ; Lang, Jennifer K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-1929dc15d5aebdef077266b0a41e59f478735416823bff4a0276ddae7f830c603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Apoptosis</topic><topic>Biochemistry</topic><topic>Biocompatible Materials</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biomimetics</topic><topic>Biotechnology</topic><topic>Cell Engineering</topic><topic>Drug Delivery Systems</topic><topic>Extracellular Vesicles</topic><topic>Humans</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Review Article</topic><topic>Terminology as Topic</topic><topic>Theme: Therapeutic and Diagnostic Applications of Exosomes and other Extracellular Vesicles</topic><topic>Therapeutics</topic><topic>Tissue Distribution</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mentkowski, Kyle I.</creatorcontrib><creatorcontrib>Snitzer, Jonathan D.</creatorcontrib><creatorcontrib>Rusnak, Sarah</creatorcontrib><creatorcontrib>Lang, Jennifer K.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The AAPS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mentkowski, Kyle I.</au><au>Snitzer, Jonathan D.</au><au>Rusnak, Sarah</au><au>Lang, Jennifer K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic Potential of Engineered Extracellular Vesicles</atitle><jtitle>The AAPS journal</jtitle><stitle>AAPS J</stitle><addtitle>AAPS J</addtitle><date>2018-03-15</date><risdate>2018</risdate><volume>20</volume><issue>3</issue><spage>50</spage><epage>50</epage><pages>50-50</pages><artnum>50</artnum><issn>1550-7416</issn><eissn>1550-7416</eissn><abstract>Extracellular vesicles (EVs) comprise a heterogeneous group of small membrane vesicles, including exosomes, which play a critical role in intracellular communication and regulation of numerous physiological processes in health and disease. Naturally released from virtually all cells, these vesicles contain an array of nucleic acids, lipids and proteins which they transfer to target cells within their local milieu and systemically. They have been proposed as a means of “cell-free, cell therapy” for cancer, immune disorders, and more recently cardiovascular disease. In addition, their unique properties of stability, biocompatibility, and low immunogenicity have prompted research into their potential as therapeutic delivery agents for drugs and small molecules. In this review, we aim to provide a comprehensive overview of the current understanding of extracellular vesicle biology as well as engineering strategies in play to improve their therapeutic potential.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>29546642</pmid><doi>10.1208/s12248-018-0211-z</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1550-7416
ispartof The AAPS journal, 2018-03, Vol.20 (3), p.50-50, Article 50
issn 1550-7416
1550-7416
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8299397
source Springer Nature
subjects Apoptosis
Biochemistry
Biocompatible Materials
Biomedical and Life Sciences
Biomedicine
Biomimetics
Biotechnology
Cell Engineering
Drug Delivery Systems
Extracellular Vesicles
Humans
Pharmacology/Toxicology
Pharmacy
Review Article
Terminology as Topic
Theme: Therapeutic and Diagnostic Applications of Exosomes and other Extracellular Vesicles
Therapeutics
Tissue Distribution
title Therapeutic Potential of Engineered Extracellular Vesicles
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T21%3A55%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20Potential%20of%20Engineered%20Extracellular%20Vesicles&rft.jtitle=The%20AAPS%20journal&rft.au=Mentkowski,%20Kyle%20I.&rft.date=2018-03-15&rft.volume=20&rft.issue=3&rft.spage=50&rft.epage=50&rft.pages=50-50&rft.artnum=50&rft.issn=1550-7416&rft.eissn=1550-7416&rft_id=info:doi/10.1208/s12248-018-0211-z&rft_dat=%3Cpubmed_cross%3E29546642%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-1929dc15d5aebdef077266b0a41e59f478735416823bff4a0276ddae7f830c603%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/29546642&rfr_iscdi=true